Finance

Lists
Why is YATHARTH down 2,52%?
Dive Deeper
YATHARTH:NSE
Yatharth Hospital & Trauma Cre Srvcs Ltd
₹1 007,70
-2,52%
(-26,00) 1D
5 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for YATHARTH...
Open
₹1 028,60
High
₹1 039,70
Low
₹995,00
Mkt. cap
96,87 mjd
Avg. vol.
790,28 k
Volume
435,16 k
Dividend
0,05%
Quarterly dividend
₹0,13
Ex-dividend date
14 Aug. 2026
P/E ratio
53,83
52-wk high
₹1 184,00
52-wk low
₹538,25
EPS
₹18,72
No. of employees
7 k
Open
₹1 028,60
High
₹1 039,70
Low
₹995,00
Mkt. cap
96,87 mjd
Avg. vol.
790,28 k
Volume
435,16 k
Dividend
0,05%
Quarterly dividend
₹0,13
Ex-dividend date
14 Aug. 2026
P/E ratio
53,83
52-wk high
₹1 184,00
52-wk low
₹538,25
EPS
₹18,72
No. of employees
7 k
News stories
From web sources and news partners
Profile
Yatharth Hospital & Trauma Care Services Ltd is an Indian for-profit private hospital chain of North India. It operates 8 hospitals with more than 2500 beds in four states of India. It was founded by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar in 2008. All of its hospitals are accredited by NABH. Its facility in Greater Noida West is the first and only hospital in Uttar Pradesh to be accredited by Joint Commission International. Wikipedia
About Yatharth Hospital & Trauma Cre Srvcs Ltd
CEO-
Employees7,44 k
Founded2008
Headquarters-
SectorHealth care provider
Last report
11 Aug. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
3,93 mjd / 3,56 mjd
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,79 mjd
3,20 mjd
3,50 mjd
3,93 mjd
Cost of goods sold
1,10 mjd
1,26 mjd
1,31 mjd
1,47 mjd
Cost of revenue
1,10 mjd
1,26 mjd
1,31 mjd
1,47 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
309,43 m
-
Operating expense
1,24 mjd
1,44 mjd
1,58 mjd
1,82 mjd
Total operating expenses
2,34 mjd
2,70 mjd
2,90 mjd
3,29 mjd
Operating income
455,91 m
502,89 m
598,44 m
634,44 m
Other non operating income
94,89 m
78,25 m
-231,48 m
43,53 m
EBT including unusual items
548,23 m
570,97 m
529,52 m
612,05 m
EBT excluding unusual items
548,23 m
570,97 m
506,66 m
612,05 m
Income tax expense
135,70 m
140,14 m
90,22 m
157,82 m
Effective tax rate
24,75%
24,54%
17,04%
25,79%
Other operating expenses
1,05 mjd
1,20 mjd
974,49 m
1,54 mjd
Net income
412,42 m
453,51 m
467,52 m
470,61 m
Net profit margin
14,76%
14,15%
13,38%
11,99%
Earnings per share
-
-
-
-
Interest and investment income
-
-
195,32 m
-
Interest expense
-2,57 m
-10,17 m
-50,71 m
-65,92 m
Net interest expenses
-2,57 m
-10,17 m
144,61 m
-65,92 m
Depreciation and amortization charges
189,31 m
239,60 m
299,96 m
282,38 m
EBITDA
625,16 m
639,36 m
807,46 m
853,96 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme